InvestorsHub Logo
Followers 832
Posts 119981
Boards Moderated 17
Alias Born 09/05/2002

Re: stugwins post# 435

Monday, 06/20/2016 2:13:55 PM

Monday, June 20, 2016 2:13:55 PM

Post# of 592

Bendeka was TEVA’s hedge in case the Treanda litigation didn't pan out for them. Now that they won you will witness the "revival" of lyophilized Treanda.

That’s nonsense. Teva made the switch from lyo to liquid in 2013—long before partnering with EGRX (http://www.businesswire.com/news/home/20130917006088/en/FDA-Approves-Teva%E2%80%99s-TREANDA%C2%AE-bendamustine-HCI-Injection ).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EGRX News